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Abstract
The human-adapted Salmonella enterica serovar Typhi (S. Typhi) causes a systemic infection known as typhoid fever. This
disease relies on the ability of the bacterium to survive within macrophages. In order to identify genes involved during
interaction with macrophages, a pool of approximately 10
5 transposon mutants of S. Typhi was subjected to three serial
passages of 24 hours through human macrophages. Mutants recovered from infected macrophages (output) were
compared to the initial pool (input) and those significantly underrepresented resulted in the identification of 130 genes
encoding for cell membrane components, fimbriae, flagella, regulatory processes, pathogenesis, and many genes of
unknown function. Defined deletions in 28 genes or gene clusters were created and mutants were evaluated in competitive
and individual infection assays for uptake and intracellular survival during interaction with human macrophages. Overall, 26
mutants had defects in the competitive assay and 14 mutants had defects in the individual assay. Twelve mutants had
defects in both assays, including acrA, exbDB, flhCD, fliC, gppA, mlc, pgtE, typA, waaQGP, SPI-4, STY1867-68, and STY2346. The
complementation of several mutants by expression of plasmid-borne wild-type genes or gene clusters reversed defects,
confirming that the phenotypic impairments within macrophages were gene-specific. In this study, 35 novel phenotypes of
either uptake or intracellular survival in macrophages were associated with Salmonella genes. Moreover, these results reveal
several genes encoding molecular mechanisms not previously known to be involved in systemic infection by human-
adapted typhoidal Salmonella that will need to be elucidated.
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Introduction
The human specific pathogenic bacteria Salmonella enterica
serovar Typhi (S. Typhi) is responsible for the systemic infection
known as typhoid fever. Epidemiological studies show that in
2000, typhoid fever caused nearly 22 million infections, while
killing more than 200 000 individuals in endemic countries of the
world [1]. Unfortunately, multidrug-resistant strains of S. Typhi
are arising in many of these regions, rendering typhoid treatment
more complex and difficult than ever [2]. Hence, there is a critical
need to uncover new potential therapeutic targets within this
pathogen, leading to either new antimicrobials or more effective
vaccine therapy against typhoid fever [3].
Survival of Salmonella within macrophages is crucial for systemic
infection, since mutants that fail to replicate in these cells in vitro
are avirulent in animals [4]. Thus, macrophage infection
represents a good model for the study of Salmonella genes involved
in virulence. Genes playing a role in intracellular survival within
macrophages have been identified. Some of these include the
phoPQ regulatory system [5–8] as well as components of the type
three secretion system (T3SS) encoded by Salmonella pathogenicity
island (SPI)-2 genes [9–11]. The critical role of SPI-2 T3SS
regarding intramacrophage survival has been clearly demonstrated
for Salmonella enterica serovar Typhimurium (S. Typhimurium) [11–
13], which causes localized gastroenteritis during human infection
and systemic disease in mice. Interestingly, although both S. Typhi
and S. Typhimurium serovars are closely related, and have about
90% of their genomes in common [14], SPI-2 T3SS was not
essential for S. Typhi survival within human macrophages [8],
whereas no major differences in SPI-2 T3SS genetic composition
were observed between both serovars [15]. Vaccine development
has also witnessed many situations where inactivation of the same
genes in both serovars led to different phenotypes in the animal
model or human host [16–21]. Moreover, the intracellular
strategies used by Salmonella are not fully understood, suggesting
that several genes used by the bacteria to survive inside
macrophages remain to be identified.
Screening methods have been developed to comprehensively
identify genes involved during infection. Signature-tagged muta-
genesis (STM) was the first technique to simultaneously screen a
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virulence genes in an animal model [22]. With this strategy,
mutants from the initial input pool that are underrepresented in
the output pool point towards candidate genes potentially involved
during infection. Recent advances, including genome sequencing
and microarrays, have led to even more sophisticated screening
techniques and have been used successfully to identify virulence
genes of S. Typhimurium in macrophages and within mice [23–
26]. In order to extend our knowledge on the genetic determinants
of Salmonella used during interaction with macrophages, such a
strategy was applied to identify genes for which mutants were
underrepresented following competitive passage of a transposon
mutant library through macrophages, with the unprecedented use
of serovar Typhi and human macrophages. Following the
screening, isogenic markerless deletion mutants were created to
verify the phenotypes associated with uptake and intracellular
survival, using mixed and individual infection experiments. Most
importantly, several new S. Typhi genes involved during
interaction with human macrophages were identified.
Materials and Methods
Bacterial strains and plasmids
Strains and plasmids used in this study are listed in Table S1.
Bacteria were routinely grown overnight statically (low aeration) in
Luria-Bertani (LB) broth and plates at 37uC, unless indicated.
Auxotrophy among deletion mutants was tested using M63-
glucose minimal medium supplemented with 40 mg/L trypto-
phan, 40 mg/L cysteine, and 0.6% (w/v) glucose during overnight
growth and optical densities at 600 nm (OD600) of these cultures
were compared to that of the wild-type. In order to evaluate
resistance of mutants to the detergent sodium deoxycholate
(DOC), bacteria were grown overnight in RPMI 1640 (Wisent)
medium containing 0.1% (w/v) DOC. OD600 were compared to
that of the wild-type. To test survival of mutant acrA in DOC,
5610
6 CFUs of an overnight culture grown statically were
inoculated in 1 ml of 0.1% (w/v) DOC in PBS. Samples were
left on ice and viable bacteria were determined as CFUs at 0 and
2 hours (h) after inoculation. When necessary, antibiotics or
supplements were added at concentrations of 50 mgm l
21 for
ampicillin (Ap), kanamycin (Km), nalidixic acid (Nal) or diamino-
pimelic acid (DAP); 34 mgm l
21 for chloramphenicol (Cm); or
50 mM isopropyl-b-D-thiogalactopyranoside (IPTG). Transforma-
tion of bacterial strains was routinely done by using the calcium/
manganese-based method or by electroporation [27].
Construction of the transposon harbouring a T7 RNA
polymerase promoter for generation of the mutant
library
A PCR-based strategy was used to insert a T7 RNA polymerase
promoter at the 39 region of the mini-Tn10-Km transposon from
the pLOFKm suicide conjugative plasmid [28], kindly provided by
Kenneth E. Sanderson, University of Calgary. This vector
contains a mini-Tn10-Km transposon with IS10 inverted repeated
sequences flanking a kanamycin resistance (Km
r) cassette and an
IPTG-inducible transposase located outside the mobile element.
The Km
r cassette was amplified with a primer that added the T7
promoter at its 39 end (Front NotI-Kan and Rear NotI-Kan)
(Table S2). The PCR product was ligated into pLOFKm, both
digested with NotI, thus creating pLOFKm-T7 (pSIF117). This
plasmid was transformed into Escherichia coli (E. coli) MGN-617
[29] and conjugated into S. Typhi wild-type strain ISP1820 [30]
with IPTG present in the agar mating plate. Approximately 10
5
transposon insertion mutants (Km
r) were obtained and represent
the library of mutants used for our screening.
Competitive selection of the mutant library in cultured
macrophages
The human monocyte cell line THP-1 (ATCC TIB-202) was
maintained in RPMI 1640 containing 10% (v/v) heat-inactivated
fetal bovine serum (Wisent), 25 mM HEPES (Wisent), 2 mM L-
glutamine (Wisent), 1 mM sodium pyruvate (Wisent) and 1%
modified Eagle’s medium nonessential amino acids (Wisent). A
stock culture of these cells was maintained as monocyte-like, non-
adherent cells at 37uC in an atmosphere containing 5% (v/v) CO2.
For screening, 10
7 macrophages were seeded in a 100620 mm
Petri dish (Sarstedt) and differentiated by addition of 10
27 M
phorbol 12-myristate 13-acetate for 48 h. Prior to infection, the
macrophage supernatant was changed with fresh medium at 37uC.
The mutant library (used as input pool) was grown overnight
statically in 20 ml LB with Km at 37uC and used to infect two
separate macrophage monolayers (generating two independent
output pools). Bacteria were added at a multiplicity of infection
(MOI) of 10 to the cell monolayer and incubated at 37uC for
30 minutes to allow internalization. This corresponds to the initial
interaction with cells, where some bacteria will be associated
(adherence) and some will be intracellular (uptake). Cells were then
washed three times with prewarmed PBS, pH 7.4, and medium
containing 100 mgm l
21 of gentamicin (Wisent) was added to kill
extracellular bacteria (0 h). After 2 h of incubation with high-
concentration gentamicin at 37uC, cells were washed and medium
containing 12 mgm l
21 of gentamicin was added for the remainder
of the experiment. After 22 h of low-concentration gentamicin
treatment (24 h post-infection), cells were washed and lysed by
addition of 10 ml 0.1% (w/v) DOC in PBS. The lysate was
centrifuged and bacteria were resuspended in 20 ml LB with Km
and grown overnight statically at 37uC for the next serial passage
in macrophages. After three serial passages through macrophages,
bacteria released from infected macrophages were grown over-
night with agitation in LB with Km at 37uC and represent the
output pools (two output pools were generated in parallel).
Bacterial cultures from the macrophage output pools and from
the initial input pool were used for genomic DNA extraction.
Amplification and labelling of transposon-flanking
sequences
Genomic DNA from the input and output pools was isolated
using phenol/chloroform extraction, followed by ethanol precip-
itation [31]. Four mg of genomic DNA from each pool was
sonicated using five pulses of two seconds each, with a Sonics &
Materials Vibra-cell VC600 device (Sonics & Materials Inc.,
Danbury, CT). Sonicated genomic DNA was then poly(A)-tailed
with terminal transferase (TdT) (New England Biolabs) and
purified as described previously [23]. Purified sonicated poly(A)-
tailed DNA obtained from input and output pools was used as
template for nested PCR reactions as previously described [23]
with some modifications, in order to specifically amplify the
segments encompassing the 39 end of the transposon (including the
inserted T7 RNA polymerase promoter) and the adjacent genomic
DNA region. Briefly, 50 ng of purified sonicated poly(A)-tailed
DNA was included in the first round of nested PCR in a total
volume of 25 mL. This reaction combined 16 PCR buffer,
0.2 mM dNTPs, 2.5 mM MgCl2, 0.2 mM primers pLOF F seq
and CCT24VN (the latter made to anneal to the poly(A)-tail), and
1.25 U Taq polymerase (Feldan). The PCR steps followed were:
initial denaturation (hot start) at 94uC for 1 minute, then 30 cycles
S. Typhi Genes Involved in Macrophage Infection
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for 30 seconds, and elongation at 72uC for 30 seconds. The
reaction ended with one last elongation at 72uC for 3 minutes.
The second round of nested PCR was done in a volume of 50 mL
and included 1 mL of the first PCR amplification reaction, internal
primer STY:PCRNiche#2 and primer CCT24VN used in the first
round. The amplified DNA was then subjected to an in vitro
transcription reaction, using the MEGAscript T7 High yield
transcription kit (Ambion) with 5 mL of the nested PCR reaction
included directly as the template in a 20 mL reaction, by following
the manufacturer’s protocol with some modifications. Briefly, the
transcription reaction was done at 37uC for 2 h, and subsequently,
the synthesized RNA was treated with DNase (Ambion) for
30 minutes at 37uC, purified with the RNeasy Mini kit (Qiagen)
and eluted in RNase-free H2O.
Purified RNA was used to synthesize labelled cDNA probes as
described previously [32], except that 4.8 mg of total RNA were
added to 4 mg of random hexamers (Sigma) and reverse
transcribed using SuperScript II reverse transcriptase (Invitrogen)
while incorporating Cy5-dCTP (Amersham Biosciences) for the
input (control sample) and Cy3-dCTP (Amersham Biosciences) for
the output (experimental sample). Labelled first-strand cDNA was
column-purified using QIAquick PCR purification kit (Qiagen),
and eluted with RNase-free H2O.
Microarray hybridization of labelled cDNA
The non-redundant Salmonella microarray that comprises .98%
of S. Typhi strain CT18 genes was used as described previously
[32,33]. Microarrays were scanned using a GenePix 4000B laser
scanner (Molecular Devices) at 5 mm resolution and signal
intensities were quantified with GenePix Pro 6.0 (Axon Instru-
ments). Background subtraction was done with GenePix Pro, by
applying the software’s default «local median intensity» subtrac-
tion method. Results were normalized and analyzed using
WebArrayDB (http://www.webarraydb.org) [34]. Genes with a
signal intensity two standard deviations above the average
background level were considered as detected [32]. The array
platform and hybridization data are MIAME-compliantly depos-
ited at http://www.webarraydb.org (MPMDB ID 144).
Generation of individual mutants and complementation
Gene deletions were generated by allelic exchange as described
previously [30], by using the overlap-extension PCR method [35].
Primers used for each gene are listed in Table S2. Mutations were
confirmed by PCR. Complementation of mutants was performed
by cloning an intact copy of the S. Typhi wild-type gene or gene
cluster into the low-copy-number vector pWSK29 [36]. This
plasmid has been shown to have no deleterious effect on S. Typhi
infection of host cells [37]. For infection assays, the complemented
strains were grown overnight in LB with Ap.
Infection assays of cultured human macrophages
For competitive index (CI) experiments in macrophages [38], a
spontaneous nalidixic acid-resistant (Nal
r) S. Typhi ISP1820 strain
was used as the wild-type (DEF566). This Nal
r strain showed no
intracellular attenuation compared with strain ISP1820 when both
were used in a CI experiment in THP-1 macrophages [8]. The
wild-type and mutant strains used for competition experiments
were separately grown overnight (static) in LB broth and the
concentration (CFU/ml) of each strain was evaluated by OD600 of
the suspension culture. CFU counts obtained by plating on LB
agar with and without antibiotic assessed that the mixture
contained equivalent numbers of actual viable bacteria from each
strain. The 1:1 mixture (CFU/ml) of the two cultures was added to
the THP-1 cell monolayer as described above for screening of the
mutant library, except that cells were seeded at 5610
5 cells per
well in 24-well tissue-culture dishes at an MOI of 50 [38]. Cells
were lysed by addition of 1 ml 0.1% (w/v) DOC in PBS per well,
and the numbers of viable intracellular bacteria were determined
as CFUs at 0 and 24 h after infection by plating on LB agar and
on LB agar with antibiotic. For CI experiments involving plasmid-
rescued mutant strains, the complemented mutant was grown
overnight separately in LB broth with Ap, resuspended in LB
without antibiotic, and used to prepare a 1:1 mixture (CFU/ml)
with the mutant. The CI for bacterial uptake is defined as the
mutant to wild-type ratio of bacteria recovered at 0 h divided by
the equivalent ratio of bacteria in the mixed inoculum. The CI for
bacterial survival is defined as the mutant to wild-type ratio of
bacteria recovered at 24 h post-infection divided by the equivalent
ratio of bacteria recovered at 0 h. Results are expressed as the
mean 6 standard error of the mean (SEM) of at least three
independent experiments performed in duplicate and Student’s
two-tailed t-test was used for statistical analysis.
Macrophage infection with individual mutants was performed
as described above for the CI assay, except that an MOI of 10 was
used. Bacterial uptake was defined as the number of bacteria
recovered at 0 h after infection divided by the number of bacteria
in the inoculum. Survival was defined as the number of bacteria
recovered 24 h after infection divided by the number of bacteria
recovered at 0 h. In order to compare data from different
experiments, the values representing recovery percentages were
then normalized relative to that of the wild-type control, which
was designated 100% at each time point, unless indicated. Results
are expressed as the mean 6 SEM of at least three independent
experiments performed in duplicate and Student’s two-tailed t-test
was used for statistical analysis.
Motility assay
Mutants were tested for their ability to swim in LB 0.3% agar
plates as previously described [39], with some modifications. Prior
to inoculation, the plates were allowed to dry for 1 h under a
sterile laminar flow hood at room temperature. Strains were
grown overnight with agitation in LB at 37uC, were then diluted
1:100 in LB and grown with agitation at 37uCt oa nO D 600
ranging from 0.4 to 0.5. Each mutant strain was tested along with
the wild-type counterpart, where both were spotted into the agar
using 6 mL of bacterial culture on the same swimming plate. The
plates were incubated at 30uC for 16 to 17 h, except for mutant
typA, whose swimming plate was incubated at 37uC for 10 to 11 h
(this mutant showed a reduced growth rate at 30uC compared to
37uC; data not shown) and typA, also known as bipA, has been
shown to be involved in growth at low temperature [40–43].
Following incubation, outward migration diameters for each
mutant were measured and compared to that of the respective
wild-type counterpart found on the same plate, in order to identify
mutants exhibiting a swimming defect. Motility levels of mutants
are expressed as the percentage obtained by dividing the mutant
swimming diameter by that of the wild-type (Table 1). Results
represent the mean 6 SEM of at least three independent
experimental replicates and Student’s two-tailed t-test was used
for statistical analysis.
Sensitivity of mutant strains to hydrogen peroxide
Sensitivity to hydrogen peroxide (H2O2) was evaluated by an
agar overlay diffusion method as previously described [44], with
some modifications. Mutant and wild-type strains were grown
overnight statically in LB at 37uCt oa nO D 600 ranging from 0.5 to
0.6. For each strain, 100 mL of bacterial culture were mixed to
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Uptake/Survival defects observed in
macrophages
ORF(s) (gene name)
a Description Fold-change
b
S. Typhi
c (typhoid
patients)
d
Other Salmonella
serovars Motility level (%)
e
H2O2 sensitivity
(mm)
f
Cell envelope
STY0520 (acrA) Acriflavine
resistance protein
24.13 uptake/survival (AcrA) uptake [63] - -
STY2167 (fliC) flagellin 22.72 uptake/survival uptake [97] 20 (60.7)
g -
STY2632 (pgtE) outer membrane
protease E
23.20 uptake survival [98] - -
STY4071-73 (waaQGP) LPS core
biosynthesis
proteins
23.25 uptake/survival survival [92,93] 62 (611.9)
g 3( 60.6)
STY2303-04 (rfbIC) O-Ag biosynthesis 22.87/23.48 survival ND
h 70 (65.7)
g -
STY0024-34 (bcfABC
iDEFGH) fimbrial structure 22.12 uptake (BcfD) ND - 1.3 (60.3)
g
STY1176-82 (csgGFEDBAC) fimbrial structure 24.74 uptake (CsgEFG) ND - -
STY0369-73 (stbABCDE) fimbrial structure 23.69 uptake (StbD) ND - -
STY2378-81 (stcABCD) fimbrial structure 22.85 survival ND - 2 (61.0)
STY0041 putative exported
protein
25.75 survival ND - -
STY1358-67
j (64) genetic island 23.47 ND (STY1364) ND - 2.5 (60.5)
g
STY1867-1868 putative proteins 25.46/24.14 uptake/survival ND - 1.5 (60.5)
Pathogenesis
STY2753-63a (sinH
i) pathogenicity
island (CS54)
22.32 uptake (ShdA
i)N D - -
STY1878 (pagC) outer membrane
invasion protein
22.23 uptake/survival (PagC) survival [6] - -
STY3004 (sipF) acyl carrier protein
(SPI-1)
25.00 uptake/survival ND - -
STY4452-60 (siiABCDE
iF) T1SS and adhesin
(SPI-4)
23.55/23.43/
22.35
uptake/survival ND - 2 (60.0)
g
STY4679
j putative membrane
protein (SPI-7)
23.33 uptake ND 84 (62.6) -
jSTY4842-43 putative regulatory
proteins (SPI-10)
23.74 uptake/survival ND - 2.5 (60.5)
Regulatory functions
STY2133-34 (flhCD) flagellar master
regulators
23.22 uptake/survival ND 21 (60.9)
g -
STY3641 (gppA) guanosine
pentaphosphatase
24.16 uptake/survival ND - 2 (60.6)
g
STY1576 (mlc) putative regulatory
protein
22.25 survival ND - 3 (60.0)
g
STY3871 (typA) GTP-binding
protein
22.94 uptake/survival ND 76 (64.5)
g, k 2( 60.0)
Transport and binding
proteins
STY3331-32 (exbDB) biopolymer
transport proteins
26.04/23.53 uptake/survival ND - 1.5 (60.9)
STY1649 (ompN) outer membrane
protein N
23.87 survival ND - -
Unknown function
STY0016 hypothetical
protein
23.13 ND ND - -
STY1398 hypothetical
protein
23.84 survival ND - 1.5 (60.5)
STY1869 hypothetical
protein
22.10 uptake/survival ND - -
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evenly over an LB plate (1.5% agar) and let to dry at room
temperature until the top agar had completely solidified. One filter
paper disc (6 mm diameter; Becton Dickinson) was then placed at
the center of the solidified overlay, and 10 mL of 29.9% H2O2
(Sigma) were spotted onto the disc. Plates were incubated
overnight at 37uC, and following growth, the diameters of
inhibition zones of the mutants were measured and compared to
that of the wild-type counterpart. H2O2 sensitivity of mutants was
defined as the difference in mm between the mutant inhibition
zone and that of the wild-type (Table 1). Results represent the
mean 6 SEM of at least two independent experimental replicates
and Student’s two-tailed t-test was used for statistical analysis.
Results
Genome-wide mutagenesis of S. Typhi
In order to identify S. Typhi genes involved in interaction with
human macrophages, a library of transposon insertion mutants
was constructed by conjugative transfer of the mini-Tn10-T7
transposon into the S. Typhi wild-type strain ISP1820 [45]. A
library of approximately 10
5 mutants was generated. Southern
blot analysis of some of the transposon mutants was used to verify
and to confirm that the mutagenesis resulted in single random
insertions (data not shown). Moreover, 3859 out of 4452 S. Typhi
genes printed on the microarray were detected in the input library
(data not shown).
Competitive selection of transposon mutant library in
macrophages
The transposon mutant library was subjected to three rounds of
competitive serial passages through human cultured THP-1
macrophages. Bacterial genomic DNA from output pools follow-
ing passages through cells and from the unpassaged input pool was
extracted. From these, probes corresponding to DNA adjacent to
the transposon were synthesized and labelled for microarray
hybridization, in order to target S. Typhi genes selected following
competitive passages through macrophages. 130 genes were
identified as potentially involved due to negative selection of
transposon mutants (Table S3), by using a four-fold change
threshold (input:output ratio of 4:1, log 2
output
input

ƒ{2) and a P-
value,0.0005. Among these selected genes, we found many for
biogenesis of lipopolysaccharides (LPS), fimbriae and flagella, as
well as virulence genes (Table S3). Additionally, many of these
selected genes are part of SPIs-1, -2, -4, -5, -6, -7, -10, -11, -12, -
13, and -16 from S. Typhi. The 130 genes, corresponding to
mutants underrepresented during the competitive screening assay,
were grouped into functional classes based mainly on the Sanger
Institute classification (http://www.sanger.ac.uk) (Figure 1). The
most highly represented classes were Cell envelope (24%), Unknown
function (18%), Pathogenesis (15%), and Transport and binding proteins
(12%). Only 10 of these 130 genes were previously selected as less
fit during repeated passages of an S. Typhi mutant library in rich
media (btuC, gpmA, kdgA, mlc, prc, proC, rplS, ycdC, waaG, and ybiS)
(Table S3) [46].
In vitro characterization of markerless deletion mutants
A total of 28 isogenic markerless deletion mutants were
generated in S. Typhi strain ISP1820 (Table 1), chosen from the
top functional classes of genes (Figure 1). The deletions were gene-
specific and nonpolar or sometimes targeted a gene cluster, such as
a complete operon (or putative operon) or a portion of it. Clusters
include exbDB, waaQGP, rfbIC, the bcf, csg, stb, and stc fimbrial
operons, STY1358-67, STY1867-1868, the CS54 pathogenicity
island, SPI-4, STY4842-4843 from SPI-10, and flhCD. Each of
these clusters includes at least one of the selected genes (bold)
(Table S3). We first determined if gene inactivation of our mutants
affected growth in vitro. All deletion mutants had growth curves in
LB broth similar to that of the wild-type strain, except mutants
waaQGP and mlc which had a slight defect (data not shown).
Growth deficiency for these mutants has been previously observed
[47,48]. None of the mutants demonstrated auxotrophy when
grown in M63-glucose minimal medium (data not shown).
Resistance to the detergent DOC, as used in the infection assays,
was also verified for all of the mutants. Only mutant acrA failed to
Table 1. Cont.
Uptake/Survival defects observed in
macrophages
ORF(s) (gene name)
a Description Fold-change
b
S. Typhi
c (typhoid
patients)
d
Other Salmonella
serovars Motility level (%)
e
H2O2 sensitivity
(mm)
f
STY2346 hypothetical
protein
24.47 uptake ND - 2 (61.0)
aLoci which have been inactivated in each of the 28 markerless deletion mutants created for this study are listed. Numbers or characters in bold among a gene cluster
represent ORF(s) or genes selected following initial screening through macrophages.
bLog2 of output/input values for genes identified following screening of mutant pool through macrophages. For gene clusters, the fold-changes are associated to
selected genes (bold) among the cluster.
cPhenotypes have been deduced from results of competitive assays in combination with those from individual infections performed in this study using S. Typhi deletion
mutants, the wild-type strain, and the nalidixic acid-resistant wild-type strain (DEF566).
dGene or ORF products which are among S. Typhi antigens detected in blood of typhoid fever patients according to previous studies [56–58].
ePercentages represent mutant swimming diameter in mm divided by that of the wild-type, thus indicating the level of motility remaining for the mutantsi n
comparison to the wild-type. Results represent the mean 6 standard error of the mean (SEM) of at least three independent experimental replicates and Student’s two-
tailed t-test was used for statistical analysis.
fValues were obtained by subtracting mutant inhibition diameter in mm by that of the wild-type. Results represent the mean 6 SEM of at least two independent
experimental replicates and Student’s two-tailed t-test was used for statistical analysis.
gResults for mutant are significantly different from those of the wild-type (P,0.05).
hND, no defects during interaction with macrophages are reported in previously published literature on Salmonella serovars other than Typhi.
iPseudogene in S. Typhi strains CT18 [66] and Ty2 [99].
jUnique to S. Typhi compared to S. Typhimurium [66].
kMotility assay was done at 37uCf o rDtypA, instead of 30uC used for other mutants, since this mutant exhibited reduced in vitro growth at 30uC (data not shown).
doi:10.1371/journal.pone.0036643.t001
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approximately 10% mortality over 2 h in PBS with 0,1% DOC.
Motility is a property that has been previously associated with S.
Typhi virulence towards eukaryotic cells [49], thus the abilities of
the mutants to swim in soft agar was evaluated. Mutants fliC,
waaQGP, rfbIC, flhCD, and typA swam significantly less in LB 0.3%
agar plates than the wild-type strain (P,0.05), and mutant
STY4679 also exhibited a swimming defect that was not significant
(P=0.226) (Table 1). The motility defect was expected for mutants
flhCD and fliC, as they represent the master regulators and main
structural subunit of the flagellar system, respectively [50].
Mutation of waaG (rfaG) was previously shown to affect swimming
motility in E. coli, S. Typhimurium and S. Typhi [47,51,52].
Phagocytic cells are able to produce reactive oxygen species, such
as H2O2, as part of defense mechanisms against invading
microorganisms [53]. Hence, we investigated sensitivity of the
mutants when exposed to oxidative stress mediated by H2O2.
Mutants waaQGP, bcf, stc, STY1358-67, STY1867-68, SPI-4,
STY4842-43, gppA, mlc, typA, exbDB, STY1398, and STY2346
showed a slightly higher sensitivity relatively to the wild-type
strain. These higher sensitivities were significant for mutants bcf,
STY1358-67, SPI-4, gppA, and mlc (P,0.05) (Table 1).
Interaction of deletion mutants with macrophages
during competitive assay
During the initial screening through macrophages, transposon
mutants from the library were competing against each other while
entering into and replicating inside the cells. Hence, the deletion
mutants were tested using a competitive assay, where a Nal
r
isogenic S. Typhi strain (DEF566) was used as the wild-type
counterpart. CI values of mutants upon uptake (0 h) and during
survival (24 h post-infection) were obtained. Nine mutants had a
significantly lower CI upon uptake by macrophages (pgtE, bcf, csg,
stb, STY1867-68, CS54, STY4679, STY4842-43, and STY2346),
and eight mutants were significantly less competitive during
intramacrophage survival (ompN, rfbIC, stc, STY0041, pagC, gppA,
mlc, and STY1398)( P,0.05) (Figure 2). Furthermore, nine mutants
were significantly outcompeted by the wild-type for both uptake
and survival within macrophages (acrA, exbDB, fliC, waaQGP, sipF,
SPI-4, flhCD, typA, and STY1869)( P,0.05) (Figure 2).
Mutants highly defective during interaction with macrophages,
such as fliC, waaQGP, and flhCD, and those representing genes of
unknown function, such as STY1398, STY1869, and STY2346,
were complemented by a wild-type copy of the gene(s). These
strains were used for competitive infection of macrophages with
their corresponding mutants. The competition between the
Figure 1. Functional classification of 130 S. Typhi genes identified following competitive selection in macrophages. Functional classes
are indicated on the left and the number of genes within a class is indicated in bold on the right of each bar. The number of mutants created among
each class is shown in parentheses on the left of each class.
doi:10.1371/journal.pone.0036643.g001
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types observed against the wild-type strain (Table 2). Comple-
mented strains outcompeted their mutant counterparts at the
uptake and survival stages, except for waaQGP at uptake
(CI=1.04) and STY1398 during intracellular survival (CI=1.19).
Interaction of deletion mutants with macrophages tested
individually
The deletion mutants were individually assessed for their ability
to infect macrophages. Hence, the rates of uptake and intracellular
survival within human macrophages were determined for all the S.
Typhi mutants, and compared with those of the isogenic wild-type
strain, tested in parallel. Six mutants showed significantly lower
Figure 2. Uptake and intracellular survival of mutants within macrophages during the mixed infection assay. Competitive index (CI)
assays for uptake (0 h) and intracellular survival (24 h post-infection) against the nalidixic acid-resistant wild-type S. Typhi (DEF566) were performed
for all 28 isogenic mutants during infection of cultured THP-1 human macrophages. Functional classes are indicated below the gene names. Data
presented are the mean 6 standard error of the mean of at least three independent experiments performed in duplicate. Asterisks (*) represent CI
values for mutants which are significantly different from 1 (P,0.05).
doi:10.1371/journal.pone.0036643.g002
Table 2. Effect of plasmid-borne gene complementation on S. Typhi deletion mutants during competitive assays within
macrophages.
CI
a value for uptake CI value for survival
ORF(s) (gene name) vs wild-type
b vs complemented mutant
c vs wild-type vs complemented mutant
STY2167 (fliC) 0.33 (60.07) *
d 0.42 (60.09) * 0.41 (60.16) * 0.10 (60.07) *
STY4071-73 (waaQGP) 0.28 (60.09) * 1.04 (60.14) 0.11 (60.06) * 0.19 (60.10) *
STY2133-34 (flhCD) 0.07 (60.07) * 0.16 (60.05) * 0.00 (60.00) * 0.07 (60.07) *
STY1398 0.70 (60.13) 0.97 (60.19) 0.39 (60.12)* 1.19 (60.13)
STY1869 0.76 (60.11) * 0.73 (60.03) * 0.37 (60.15) * 0.53 (60.10) *
STY2346 0.57 (60.03) * 0.67 (60.12) * 1.19 (60.09) 0.76 (60.12)
aCI, competitive index.
bThe wild-type counterpart is represented by the nalidixic acid-resistant wild-type S. Typhi (DEF566).
cComplemented mutants all carry the low-copy-number cloning vector pWSK29 [36] harbouring the respective deleted gene or gene cluster.
dData presented are the mean 6 standard error of the mean of at least three independent experiments performed in duplicate, where the deletion mutants were mixed
either with the wild-type strain or the respective complemented mutant during infection of human macrophages. Asterisks (*) represent CI values for mutants which are
significantly different from 1 (P,0.05).
doi:10.1371/journal.pone.0036643.t002
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STY2346) and two mutants showed significantly lower intracellular
survival (STY4842-43 and mlc)( P,0.05) (Figure 3). Moreover, six
mutants had a global interaction defect towards macrophages,
with significant attenuation phenotypes observed both upon
uptake and during survival (acrA, fliC, waaQGP, STY1867-68,
flhCD, and gppA)( P,0.05) (Figure 3). The strongly attenuated
mutant acrA was complemented with wild-type acrA (pWSKacrA).
The significant survival defect within macrophages (P,0.05) was
reversed in this complemented strain, as intracellular growth from
0 to 24 h post-infection was equivalent to that of the wild-type
strain (Figure 3), hence confirming that the growth defect observed
for the mutant was due to inactivation of acrA.
Overall, infection results of deletion mutants revealed that
several mutants had a significant defect only during the
competition experiment, including eight mutants during uptake
(bcf, csg, stb, CS54, sipF, STY4679, STY4842-43, and STY1869) and
11 mutants defective in survival (exbDB, ompN, rfbIC, stc, STY0041,
pagC, sipF, SPI-4, STY1398, typA, and STY1869)( P,0.05) (Figures 2
and 3). Interestingly, 12 mutants were significantly attenuated
when subjected to both individual and competitive experiments,
with 10 mutants in uptake (acrA, exbDB, fliC, pgtE, waaQGP,
STY1867-68, SPI-4, flhCD, typA, and STY2346), and six mutants in
survival (acrA, fliC, waaQGP, flhCD, gppA and mlc)( P,0.05)
(Figures 2 and 3).
Discussion
One of the key virulence features of Salmonella is its ability to
survive inside macrophages, enabling the pathogen to systemically
infect its animal [4] or human host [54]. To better understand
how S. Typhi adapts to the macrophage environment, a
comprehensive method was applied to screen for candidate genes
used by S. Typhi during infection of human macrophages. Serial
competitive passages of a transposon mutant library through
macrophages led to the identification of 130 genes, belonging to 13
functional classes (Figure 1). Some of these genes were previously
identified following screening of S. Typhi mutant pool within
humanized mice (STY0016, STY0039, STY2607, ydhO and
STY4458) [55] and antibodies against some of their products
(CdtB, AcrA, PagC, PflB, STY1364, members of the bcf, csg, stb
fimbrial operons and of the CS54 island) were detected in blood
from typhoid patients [56–58], suggesting the importance of these
proteins during S. Typhi systemic infection of its human host.
Surprisingly, comparison of genes selected inside human
macrophages with transcriptomic data obtained at 24 h post-
infection [33] revealed that among the 130 genes identified, only
8% (10 genes) were also upregulated inside these cells. A lack of
correlation between expression and a fitness role for genes inside
macrophages was also observed with the human-adapted patho-
gen Mycobacterium tuberculosis [59]. This suggests that bacterial genes
Figure 3. Uptake and intracellular survival rates of mutants tested individually in macrophages. THP-1 human macrophages were
infected with S. Typhi wild-type strain ISP1820, all 28 isogenic mutants, and the complemented DacrA(pWSKacrA) strain. The number of intracellular
bacteria was determined upon uptake (0 h) and during survival (24 h post-infection) within macrophages. Functional classes are indicated below the
gene names. The values for percent recovery were normalized to the wild-type control value, defined as 100% at each time point. Data presented are
the mean 6 standard error of the mean of at least three independent experiments performed in duplicate. Asterisks (*) represent percentages for
mutants which are significantly different from the isogenic wild-type (P,0.05).
doi:10.1371/journal.pone.0036643.g003
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overexpressed at 24 h post-infection, but may be already expressed
upon uptake or earlier during intracellular survival.
We constructed 28 isogenic markerless deletion mutants
representing genes or gene clusters that belong to the five major
functional classes (Figure 1). Competitive and individual infection
assays were then conducted with these mutants to better determine
involvement of genes during interaction with human macrophag-
es. Using these assays, 35 defective phenotypes of either uptake or
intracellular survival within macrophages were observed for the
mutants (Table 1), all previously unassociated to the Salmonella
genes studied here. 26 mutants were less competitive than the
wild-type strain during either uptake into cells, intracellular
survival or both of these processes (Figure 2), corroborating the
selection of genes during the competitive screening strategy.
Among these 26 mutants outcompeted by the wild-type strain
during infection, six were resubmitted to competition experiments
against their respective mutant bearing the plasmid-borne wild-
type gene or gene cluster (Table 2). All mutant defects initially
identified against the wild-type counterpart were maintained
(Table 2), thus directly linking the genes complemented here to the
attenuation phenotypes in intracellular survival observed during
competition, with the exception of STY1398. The reasons
explaining the failure to complement the STY1398 mutant may
result from plasmid loss or imbalance in gene copy-number.
Moreover, when mutants were tested individually, a significant
defect was observed in half of them (14 of 28 mutants) either upon
uptake and/or during intracellular survival (Figure 3). Hence, the
competitive assay was more sensitive than the individual infection
assay in determining mutant impairment during bacterial infection
of macrophages. Noticeable is that all the fimbrial mutants showed
involvement only when under competition against the wild-type,
either upon uptake (bcf, csg, stb) or during intracellular survival (stc)
(Figure 2). In contrast, our results show a few examples of
attenuation only when mutants were subjected to individual
infection assay. This is possible if a mutant impaired when tested
alone is rescued in trans by a product of the wild-type strain during
the competitive assay, a phenomenon previously described in
competition experiments [23,26]. This was observed for mutants
pagC and gppA upon entry in macrophages and mutants STY1867-
68 and STY4842-43 during intracellular survival (Figures 2 and 3).
For example, the PagC protein is important for induction of
membrane vesicles released by S. Typhimurium in the extracel-
lular environment [60]. This suggests that presence of vesicles
produced by the wild-type strain in the surroundings of the pagC
mutant could overcome its inability to secrete vesicle-associated
virulence factors participating in macrophage infection. Only
mutants STY0016 and STY1358-67 showed no significant
attenuation when tested in competition or individually. However,
phenotypes of impairment upon uptake or during intracellular
survival may possibly be revealed only following multiple serial
passages through macrophage infection assays, similar to the initial
screening.
Among the deletion mutants, several defects of uptake and/or
survival during infection of macrophages were observed for the
first time in Salmonella (Table 1). For instance, mutation of exbDB in
S. Typhi impaired both uptake and survival in macrophages
(Figures 2 and 3). ExbD and ExbB interact with TonB, forming a
complex transducing energy to outer membrane transporters. The
exbDB mutant was probably affected in tonB-dependant substrate
acquisition inside human macrophages, however the reason
explaining the entrance defect remains unclear. The efflux pump
component AcrA [61,62] promoted S. Typhi uptake, which is
similar to that observed in S. Typhimurium [63], but was also
involved in survival up to 24 h post-infection inside human
macrophages (Figures 2 and 3). Previous transcriptomic results
have shown that inactivation of acrA in S. Typhimurium decreased
expression of phoP [64], part of the two-component phoPQ system
playing a key role in intracellular survival of Salmonella inside
macrophages, thus explaining attenuation of the S. Typhi acrA
mutant within macrophages observed here. Furthermore, an S.
Typhimurium acrA mutant was affected in growth under anaerobic
conditions after 24 h [64]. Hence, since the Salmonella-containing
vacuole within infected cells is considered hypoxic [65], it can be
postulated that inactivation of acrA in the S. Typhi mutant is in fact
impairing the ability of the bacteria to replicate under such
anaerobic conditions. However, it is less clear why the mutant is
defective in uptake inside macrophages, although it has been
proposed that lack of acrA creates membrane instability, which
may confer poor entrance inside eukaryotic cells [64]. Although
the acrA mutant was less resistant to 0.1% DOC in PBS over 2 h
(10% mortality), bacteria were exposed to this compound for a
much shorter time period following macrophage cell lysis when
conducting infection assays. Moreover, the mortality rate of the
mutant during intracellular survival in macrophages was much
higher (approximately 80% mortality), hence its defect within
macrophages was not attributable to a strong survival defect in
DOC. Another explanation may be that membrane instability
renders the acrA mutant more sensitive to antimicrobial peptides of
the macrophage. As observed, the attenuated survival phenotype
of the mutant was complemented by a plasmid-borne wild-type
copy of the gene (Figure 3). Mutants with transposons in ORFs
STY1867, STY1868, and STY1869 were selected during screening
(Table S3). STY1867 and STY1868 are roughly 150 bp apart in
the S. Typhi genome and perhaps part of an operon, whereas
STY1869 is divergently transcribed [66]. STY1867 encodes for a
putative lipoprotein [66] that could be mediating attachment of S.
Typhi to macrophage surfaces, since uptake of mutant STY1867-
68 was affected (Figures 2 and 3). STY1868, annotated as a
putative cytochrome [66], is predicted to be an inner membrane
protein [67]. Both STY1868 and STY1869 are of unknown
function [66]. However, the S. Typhimurium homologue of
STY1868 (STM1253) is induced by the PmrA/PmrB two-
component system involved in resistance to antimicrobial peptides
[68,69], and along with the STY1869 homologue (STM1252), both
ORFs are induced by the PreA/PreB two-component system,
which itself regulates PmrA/PmrB and promotes invasion of
human epithelial cells by S. Typhimurium [70,71]. Sequence
comparison of these homologous ORFs revealed a high degree of
conservation between promoter regions of both serovars. Hence, it
can be speculated that ORFs STY1868 and STY1869 from S.
Typhi are regulated similarly to those of S. Typhimurium.
However, an STM1253 mutant showed no virulence defect in
the mouse [68]. In S. Typhi, these ORFs may be mediating uptake
and survival inside macrophages as part of the PreA/PreB
regulon. The intramacrophage survival impairment of mutant
STY1867-68 could only be observed when tested individually and
not when submitted to the competitive assay (Figures 2 and 3).
Thus, this suggests that the products of STY1867-68 in the wild-
type are able to largely alleviate defects in these genes, in trans.
Many of the underrepresented genes were located on SPIs. SPI-
1 encodes a T3SS involved in invasion of non-phagocytic
epithelial cells [72,73]. However, SPI-1 transposon mutants hilC,
prgI, sipC, sipF, spaS, and ygbA were underrepresented after passages
in macrophages (Table S3). Deletion of sipF (iacP)i nS. Typhi
impaired uptake and survival within macrophages (Figure 2). The
iacP gene has been previously associated with invasiveness of chicks
by Salmonella enterica serovar Enteritidis (S. Enteritidis) [74] and
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phenotypes in conformity with the recognized operating functions
of SPI-1. iacP was also associated with virulence of S. Typhimur-
ium during infection of the mouse [25,75]. Additionally, several
genes from SPI-1 in S. Typhi were detected as virulence
determinants when a transposon mutant pool was screened within
a humanized mouse model [55]. Together, our results suggest that
SPI-1 genes could represent S. Typhi virulence factors participat-
ing in optimal infection of human macrophages. SPI-2 encodes a
T3SS involved in intracellular survival and systemic disease of S.
Typhimurium. Genes ssaN, ssaP, ssaQ, and orf408 from SPI-2 were
identified during our screening (Table S3). However, a ssaP
mutant replicates as much as the wild-type in human macrophages
(data not shown), which correlates with previous data where
complete deletion of SPI-2 T3SS was not involved in intracellular
survival of S. Typhi in human macrophages [8]. We noticed that
input values from these SPI-2 genes were higher than the average
input intensity and that their output values were similar to the
average output intensity while remaining higher than those of the
other underrepresented genes (data not shown). SPI-4 encodes a
T1SS for a non-fimbrial adhesin, that promotes adhesion to
epithelial cells [76]. Since many SPI-4 genes were detected during
initial screening (Table S3), the entire SPI-4 region was deleted
and when tested, the mutant showed impaired uptake (Figures 2
and 3) and survival within macrophages (Figure 2). SPI-4 was
initially thought to contribute to S. Typhimurium survival within
mouse macrophages as indicated by screening of a transposon
mutant bank [4,77], but further research found no such
involvement [76,78,79]. Interestingly, the transposon mutant of
SPI-4 gene STY4458 was underrepresented following competitive
passage of an S. Typhi mutant pool in a humanized mouse
infection model, and in our screening (Table S3) [55]. Hence, our
results reiterate a potential intracellular role played by SPI-4,
shown here specifically with serovar Typhi inside macrophages,
but also identifies a role concerning uptake inside these cells
(Figures 2 and 3). SPI-7 and -10 are both unique to S. Typhi when
compared to S. Typhimurium [15]. Mutant STY4679, from SPI-7,
and STY4842-43, from SPI-10, showed defects in uptake when
under competition with the wild-type (Figure 2). Furthermore, the
SPI-10 mutant was also attenuated during intramacrophage
survival when tested individually (Figure 3).
Of genes with regulatory functions identified during screening
(Figure 1 and Table S3), we tested mutants representing flhCD, mlc,
typA and also gppA (for which the transposon mutant was strongly
underrepresented (log 2
output
input

~{4:16), although not signifi-
cantly (P-value of 0.008). All these mutants showed defective
phenotypes during infection assays with human macrophages that
were described here for the first time (Table 1). Among other
selected regulators (Table S3), the LysR-family regulator ybdO was
detected and previously identified during screening of S.
Typhimurium mutants underrepresented in murine macrophages
[24] and in a mouse model of infection [25]. The deletion of typA
affects uptake as well as intracellular survival (Figures 2 and 3).
TypA (or BipA) is a translational GTPase [80] that regulates
virulence mechanisms in E. coli [81,82]. It is involved in flagella-
associated motility and growth below 30uC [41,42] and we have
observed similar phenotypes in S. Typhi (Table 1; data not show).
It also mediates resistance to certain antimicrobial peptides in S.
Typhimurium and E. coli [81,83] and was detected as a gene
potentially involved in virulence of S. Typhimurium within a
mouse model of infection [26]. Our work attributes a novel role to
this regulatory element, linked for the first time to macrophage
infection. Nonetheless, its precise functions concerning Salmonella
virulence remain unclear, as more work is required to gain insight
on its controlled regulon. The GppA enzyme hydrolyzes
guanosine pentaphosphate (pppGpp) to guanosine tetraphosphate
(ppGpp) rapidly in vivo [84,85]. These are the two signal molecules
mediating the stringent response [86]. Defective (p)ppGpp
production causes impaired invasion and intracellular growth of
S. Typhimurium in mouse macrophages [87,88], and diminishes
invasion and intracellular growth of Salmonella enterica serovar
Gallinarum in murine and avian macrophages [89]. Thus, we
propose that the stringent response, in which gppA takes part, is
also required for full virulence of S. Typhi, and our novel results
imply that GppA is involved in interaction of Salmonella with
macrophages, since the mutant was attenuated both for uptake
and intramacrophage survival (Figures 2 and 3).
In addition to genes with novel roles within macrophages
described above, we have also confirmed defective phenotypes for
mutations of genes that have been previously identified in other
Salmonella serovars, such as those associated with LPS and flagella
biosynthesis. For example, waaG is involved in linking the outer core
to the inner core of LPS [90,91], and when the waaQGP cluster was
inactivated, uptake by human macrophages was lower compared to
the wild-type strain (Figure 3), whereas a waaG (rfaG) mutant in S.
Typhimurium shows higher uptake in murine macrophages
[92,93]. However, intracellular survival in macrophages of these
mutants is lower for both serovars (Figure 3) [92,93]. It is
noteworthy that the rfbIC mutant, encoding genes involved in O-
Ag biosynthesis [94], was outcompeted by the wild-type strain 24 h
post-infection (Figure 2). This result corroborates the previously
shown potential involvement of rfbI from S. Enteritidis during
interaction with chicken macrophages, observed by screening of a
mutant library [95]. Involvement of surface LPS during S. Typhi
infection of human macrophages was further demonstrated by
identification of outer core biosynthesis genes waaI and waaK,a n d
the O-Ag ligase gene waaL (Table S3). A waaL mutant in S.
Typhimurium is affected in intracellular growth inside murine
macrophages [92,93]. Thus, with the exception that the outer core
seems to differentially influence entry into macrophages of serovars
Typhi and Typhimurium, the survival phenotypes observed here
concerning our LPS-associated mutants in S. Typhi are similar to
those previously observed with other Salmonella serovars.
Strong attenuation was observed for flagellar mutants flhCD and
fliC during macrophage infection (Figures 2 and 3). In S.
Typhimurium, a higher replication of flhD and fljB fliC mutants
within mouse macrophages was observed [96]. In S. Enteritidis, a
fliC mutant was deficient in entry into porcine blood monocytes,
similar to S. Typhi results in human macrophages (Figure 3) [97].
flgI and fliD were also identified during our screening (Table S3).
The fliD locus in S. Typhimurium [4,77] and flgI, fliD, flhC and flhD
in S. Enteritidis [95] were identified upon passages of mutant
libraries within macrophages. Nonetheless, our study has highlight-
ed for the first time involvement of flagellar genes during
intracellular survival of serovar Typhi within human macrophages.
In conclusion, screening of a S. Typhi transposon mutant library
through cultured human macrophages for 24 h selected mutants
with less fitness in these cells and revealed 130 genes potentially
involved in interaction with macrophages. Among the defined
deletion mutants representing selected genes, a great majority were
significantly defective for uptake and/or intracellular survival
inside macrophages during competitive and individual infection
assays. Many of these were genes not previously known to
contribute to entry and to intracellular survival of serovar Typhi
within human macrophages, including cell envelope components,
SPI-encoded features, regulatory elements and many ORFs of
unknown function (Table 1). Furthermore, as attenuation of S.
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avirulence within human beings [54], S. Typhi genes involved in
infection of human macrophages represent potential targets for
improvement or development of typhoid fever therapies.
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